Myriad Genetics, Inc. (Nasdaq: MYGN) today announced that Peter D. Meldrum, president and chief executive officer, has notified the company ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Hot Mgmt Changes Management Changes Management Comments Trading Halts

Mizuho Securities Downgrades Myriad Genetics (MYGN) to NeutralFebruary 4, 2015 7:07 AM Credit Suisse Downgrades Myriad Genetics (MYGN) to UnderperformFebruary 4, 2015 6:42 AM Myriad Genetics (MYGN) Tops Q2 EPS by 5c; Cuts FY15 OutlookFebruary 3, 2015 4:08 PM Myriad Genetics (MYGN) halted news pendingFebruary 3, 2015 4:03 PM